Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morris, J. C.
Right arrow Articles by Ferrendelli, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, J. C.
Right arrow Articles by Ferrendelli, J. A.
NEUROLOGY 1987;37:1111
© 1987 American Academy of Neurology

Phenytoin and carbamazepine, alone and in combination

Anticonvulsant and neurotoxic effects

John C. Morris, MD, W. Edwin Dodson, MD, J. Michael Hatlelid, MD and James A. Ferrendelli, MD

Department of Neurology and Neurosurgery (Neurology), Washington University School of Medicine, St. Louis, MO.

Comedication with phenytoin and carbamazepine is frequently used in patients with refractory seizures, although the benefit of this strategy has not been established. To assess whether the combination is a rational anticonvulsant treatment, we determined the therapeutic index (toxicity:efficacy ratio) for the drugs, alone and together, in mice. The individual agents were virtually identical in anticonvulsant and neurotoxic activity, and combined use had no additional therapeutic advantage. Analysis of drug concentrations in brain showed an additive pharmacodynamic interaction for phenytoin and carbamazepine, indicating that the combination is unlikely to be superior to either drug alone. Thus, we find no experimental justification for the simultaneous use of phenytoin and carbamazepine in the treatment of epilepsy.

Address correspondence and reprint requests to Dr. Morris, Washington University School of Medicine, Department of Neurology and Neurosurgery (Neurology), Box 8111, 660 South Euclid Avenue, St. Louis, MO 63110.

Supported in part by an Institutional Neuropharmacology Training Grant from the Public Health Service (#5-T32-NS07129) and by the Seay Neuropharmacology Research Fellowship.

Presented in part at the thirty-sixth annual meeting of the American Academy of Neurology, Boston, MA, April 1984.

Received February 20, 1986. Accepted for publication in final form June 6, 1986.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. Kim, A. Kondratyev, and K. Gale
Antiepileptic Drug-Induced Neuronal Cell Death in the Immature Brain: Effects of Carbamazepine, Topiramate, and Levetiracetam as Monotherapy versus Polytherapy
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 165 - 173.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by AAN Enterprises, Inc.